Clinical Trials Day Wins National Recognition for Research's Unsung Heroes

WASHINGTON, DC – May 20, 2026 – In a first-of-its-kind coordinated national campaign, the professionals who form the backbone of medical innovation are receiving unprecedented official recognition. The Association of Clinical Research Professionals (ACRP) announced today that 19 state and local governments across the United States have issued formal proclamations designating May 20 as Clinical Trials Day, a victory for a workforce that has long operated behind the scenes.

The initiative, driven by ACRP members and local chapters, marks a significant milestone in elevating the public profile of the clinical research field. From the floor of the Nebraska State Capitol to the Durham City Council meeting, public officials are formally acknowledging the critical contributions of the scientists, coordinators, nurses, data managers, and patient advocates who power the development of new medicines and therapies.

A Landmark Recognition for a Vital Workforce

The wave of proclamations represents a deliberate strategy to bring the importance of clinical research out of the laboratory and into the public square. Official recognitions have been secured from the District of Columbia and eight states—including Georgia, Illinois, New Jersey, and Oregon—along with ten major cities and counties such as Los Angeles, Baltimore, and Raleigh.

“ACRP is proud to advocate for the clinical research workforce at every level—from federal to state and local,” said Susan Landis, Chief Executive Officer of ACRP. “Leading this initiative to recognize May 20 as Clinical Trials Day helps elevate the visibility of clinical research and the professionals who make it possible.”

This visibility is more than just symbolic. For the professionals on the ground, it is a meaningful validation of their complex and demanding work. The proclamations are a key part of ACRP's “Research Rising” campaign for Clinical Trials Day 2026, which aims to highlight the people behind the progress.

“This recognition is more than symbolic; it’s a meaningful acknowledgment of the clinical research professionals who make medical innovation possible every day,” said Rachana Kanvinde, President of the ACRP Atlanta Area Chapter. Kanvinde highlighted the broad coalition of experts involved, from investigators and coordinators to regulatory and quality experts, all united by a “shared commitment to advancing science, improving outcomes, and expanding access to clinical trials.”

Behind the Celebration: A Workforce Under Pressure

The timing of this heightened recognition is critical. While the proclamations celebrate success, they also cast a spotlight on a profession facing immense strain. The clinical research industry is grappling with a severe workforce crisis characterized by high turnover and persistent staffing shortages that threaten to delay the development of future medical treatments.

Recent industry reports paint a stark picture, with some data indicating that up to 95% of cancer centers are impacted by staffing issues. The demand for skilled principal investigators and research coordinators far outstrips supply, leading to significant trial delays. The COVID-19 pandemic exacerbated these issues, accelerating retirements among experienced professionals and contributing to burnout and a “Great Resignation” within the ranks.

A core challenge is the lack of a defined professional identity and career path for many roles within the field. Unlike doctors or nurses, careers as clinical research associates or data managers are not widely understood or promoted in STEM curricula. Many enter the profession by chance, leading to a fragmented pipeline and high attrition rates.

Simultaneously, the complexity of clinical trials has skyrocketed. Modern protocols involve more procedures, collect vastly more data, and require navigating a dizzying array of technological systems. This increased burden falls squarely on site staff, who often face administrative overload and burnout, further fueling the cycle of turnover.

From Scurvy to State Capitols: The Legacy of May 20

The annual observance of Clinical Trials Day on May 20 commemorates a pivotal moment in medical history. On that day in 1747, aboard the HMS Salisbury, Scottish naval surgeon Dr. James Lind conducted what is now widely regarded as the first controlled clinical trial. By systematically testing different treatments on 12 sailors suffering from scurvy, he proved that citrus fruits were a cure for the deadly disease.

Lind’s methodical approach—dividing patients into comparable groups to test specific interventions—laid the intellectual groundwork for the modern randomized controlled trial, the gold standard for medical evidence. His experiment was a turning point, demonstrating that empirical evidence, rather than tradition or theory alone, should guide medical practice.

Over the centuries, this foundation has been built upon with the development of placebos, double-blinding techniques, and robust ethical frameworks like the Nuremberg Code and Good Clinical Practice guidelines. Today's Clinical Trials Day honors not only Lind's legacy but also the millions of patient volunteers and dedicated professionals who carry his scientific spirit forward.

The Power of Grassroots Advocacy in Modern Healthcare

The success of the proclamation initiative underscores a powerful shift in healthcare advocacy. By pairing federal-level engagement with a coordinated grassroots campaign, ACRP has demonstrated how local action can build momentum for national recognition and awareness. The effort has been bolstered by major industry partners, including HCA Healthcare, Sanofi, and Thermo Fisher Scientific, as well as regulatory bodies like the U.S. Food and Drug Administration (FDA), which also officially recognizes the day.

By empowering its local chapters to engage directly with mayors, governors, and city councils, the association has effectively translated the abstract concept of “clinical research” into a tangible local issue, relevant to communities and their leaders. The organization plans to build on this year's success, expanding the proclamation initiative in the years ahead to further strengthen awareness and support for the clinical research workforce.

This growing recognition is a crucial first step. By celebrating the professionals who conduct clinical trials, the campaign aims to foster a more supportive ecosystem for medical research, inspire the next generation of talent, and ultimately, accelerate the journey from scientific discovery to patient cure. As momentum builds, the campaign serves as a powerful reminder that behind every medical breakthrough is a dedicated, and now increasingly recognized, professional workforce.